Drug Topics

NOVEMBER 24, 2023

Study authors recommend that healthcare personnel consider prioritizing influenza vaccination for patients with recent cardiovascular diseases (CVDs) in light of new evidence.

Vaccines 232

Vaccines 232

Drug Topics

SEPTEMBER 10, 2024

Researchers explored an alternative pharmacist education intervention as a way of improving pharmacist-patient conversations and decreasing vaccine hesitancy among patients.

Vaccines 201

Vaccines 201

Drug Topics

FEBRUARY 2, 2024

The vaccine showed an overall efficacy of 80% in the per-protocol analysis, with a risk reduction of 6.1 typhoid infections per 1000 vaccinated children.

Vaccines 187

Vaccines 187

Drug Topics

MARCH 13, 2024

Since changes in vaccine composition can sometimes lead to confusion or misinformation, effective communication is crucial to promote vaccine uptake.

Vaccines 201

Vaccines Communication 201

Drug Topics

OCTOBER 8, 2024

Research presented at CHEST 2024 outlined the heart failure risks associated with COVID-19 infection and emphasized the importance of vaccination to prevent adverse outcomes.

Vaccines 211

Vaccines 211

Drug Topics

JANUARY 5, 2024

A model showed that if a vaccine coverage of 66% were achieved—similar to flu vaccination coverage—it could have a budget impact of $6.48 billion over the first RSV season.

Vaccines 198

Vaccines 198

Drug Topics

FEBRUARY 15, 2024

Innovation in the vaccine area continues. In 2023, the FDA approved six vaccines, including several important firsts. But they face a difficult landscape where federal policies dictate coverage.

Vaccines 184

Vaccines Insurance FDA 184

Drug Topics

JANUARY 18, 2024

In 2023, the FDA approved six vaccines, including 2 for respiratory syncytial virus (RSV), and the first vaccine to prevent the mosquito-borne virus chikungunya.

Vaccines 187

Vaccines FDA 187

Drug Topics

JUNE 17, 2024

In an attempt to promote flu vaccination, Kristen Thorson, PharmD, encourages pharmacists to “know the power of their recommendation.”

Vaccines 199

Vaccines 199

Drug Topics

OCTOBER 10, 2024

Researchers analyzed the potential role of nonphysician health care providers to provide vaccine services outside of traditional health care settings.

Vaccines 198

Vaccines 198

Drug Topics

NOVEMBER 4, 2024

Ruth Carrico PhD, DNP, APRN, discussed the importance of annual vaccination and overall health awareness and literacy during the winter flu season.

Vaccines 210

Vaccines 210

Drug Topics

JANUARY 3, 2024

The vaccine, called mRNA-1345, demonstrated an efficacy of 83.7% against RSV-associated lower respiratory tract disease with at least 2 signs or symptoms and 82.4% against the disease with at least 3 signs or symptoms.

Vaccines 209

Vaccines 209

Drug Topics

MARCH 27, 2024

5 and the original virus strains of SARS-CoV-2 compared with Spikevax, Moderna’s licensed COVID-19 vaccine. mRNA-1283 generated a stronger immune response against both the Omicron BA.4/BA.5

Vaccines 212

Vaccines Immunization 212

Drug Topics

MAY 19, 2023

Seasonal influenza kills hundreds of thousands of people every year due to a constantly changing virus and highly inefficient vaccine production. A universal flu vaccine could deal with the first problem, and mRNA technology with the second.

Vaccines 198

Vaccines 198

Drug Topics

NOVEMBER 15, 2024

After shared decision making with their community pharmacist, patients were more likely to receive an RSV vaccine.

Vaccines 187

Vaccines 187

Drug Topics

OCTOBER 15, 2023

Goode, PharmD, director of the PGY1 Community Based Residency Program at Virginia Commonwealth University, discussed the new vaccine guidelines from ACIP. Jean-Venable R.

Vaccines 220

Vaccines 220

Drug Topics

OCTOBER 30, 2023

Prophylactic HPV vaccines have demonstrated remarkable efficacy, exceeding 98%, and they are already proving to be effective in the prevention of anogenital warts, precancerous lesions, and cancer alike.

Vaccines 201

Vaccines 201

Drug Topics

JANUARY 17, 2024

A panel of clinicians gathered to address concerns and report preliminary findings around rates of RSV incidence, hospitalization, and vaccination.

Vaccines 187

Vaccines Hospitals 187

Drug Topics

FEBRUARY 13, 2024

Drug Topics talked with Gregg Sylvester, MD, chief health officer and vice president of medical affairs at CSL Seqirus, about what can we learn from this unique situation to improve future vaccine development and distribution.

Vaccines 201

Vaccines 201

Drug Topics

JANUARY 16, 2024

Within a 12-month time frame, adjusted vaccine effectiveness against diagnosed long and probable long COVID was 41.7% and 35.4%, respectively.

Vaccines 193

Vaccines 193

Drug Topics

JANUARY 30, 2024

Findings from a recent study showed that participants who watched a video discussing COVID-19 vaccination had significantly higher knowledge scores compared to those who did not watch it.

Vaccines 199

Vaccines 199

Drug Topics

JANUARY 15, 2024

Data has indicated a potential association between COVID-19 vaccination and menstruation, but there is little evidence about this association based on chart-reviewed medical record data.

Vaccines 186

Vaccines Medical Records 186

Drug Topics

APRIL 24, 2024

In response to historically low flu vaccine coverage rates, Kristen Thorson, PharmD, urges pharmacists to think back to their pandemic immunization efforts and “know the power of their recommendation,” to boost public protection from influenza.

Vaccines 186

Vaccines Immunization 186

Drug Topics

MAY 31, 2024

Researchers addressed the association between COVID-19 vaccination status and incidents of post-COVID condition.

Vaccines 187

Vaccines 187

Drug Topics

OCTOBER 25, 2024

As the H5 bird flu outbreak gradually impacts human health in the US, health care experts weighed in on possibilities of a future vaccine.

Vaccines 187

Vaccines 187

Drug Topics

NOVEMBER 2, 2023

Vaccination can combat this risk, but not all care workers get flu shots. Care home staff play a role in transmission to elderly residents by bringing flu in from their communities, especially in winter.

Vaccines 200

Vaccines 200

Drug Topics

AUGUST 26, 2024

“While seasonal variation exists, it is expected that seniors will continue to benefit from flu vaccines that are stronger than the traditional standard-dose vaccines,” wrote investigators.

Vaccines 168

Vaccines 168

Drug Topics

DECEMBER 14, 2023

While either vaccine offers some protection, having both vaccines offers the strongest level of protection against hospitalization and severe complications like MIS-C, and death.

Vaccines 181

Vaccines Hospitals 181

Drug Topics

MARCH 19, 2024

The biotechnology company’s recombinant spike protein-based vaccine demonstrated an efficacy of 88% after 40 days, 82% after 120 days, and 77% after 180 days during the PREVENT-19 trial.

Vaccines 179

Vaccines 179

Drug Topics

SEPTEMBER 3, 2024

The protein-based vaccine includes a monovalent component corresponding to the Omicron variant JN.1 1 strain.

Vaccines 162

Vaccines FDA 162

Drug Topics

NOVEMBER 16, 2023

VAERS was designed to collect reports of symptoms, diagnoses, hospital admissions, and deaths after vaccination for postmarket safety signals.

Vaccines 187

Vaccines Hospitals 187

STAT

JUNE 11, 2024

As a co-leader of the team at the National Institutes of Health that developed technologies powering a number of Covid-19 vaccines, I often speak publicly about vaccine science, even though I no longer work for the government. There is no denying the millions of lives that Covid-19 vaccines saved.

Vaccines 145

Vaccines 145

Drug Topics

NOVEMBER 10, 2023

Ixchiq contains a live, weakened version of the chikungunya virus and may cause symptoms in the vaccine recipient similar to those experienced by people who have chikungunya disease.

Vaccines 185

Vaccines FDA 185

Drug Topics

SEPTEMBER 8, 2023

Vaxart’s VP1-based bivalent oral tablet vaccine was developed to target the norovirus GI.1 1 Norwalk and GII.4 4 Sydney strains, which are the predominant strains affecting humans.

Vaccines 187

Vaccines 187

Drug Topics

OCTOBER 2, 2023

Katalin Karikó, PhD, and Drew Weissman, MD, PhD, were cited "for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19."

Vaccines 201

Vaccines 201

STAT

MAY 13, 2024

The number of children who received their routine vaccinations declined during the pandemic, so public health officials have been focusing on getting kids back up to date. They found that adult vaccination programs paid for themselves many times over, returning up to 19 times the initial investment in societal benefits.

Vaccines 144

Vaccines Immunization 144

STAT

JULY 2, 2024

Moderna has been awarded $176 million by the Biomedical Advanced Research and Development Authority to accelerate development of messenger RNA-based pandemic influenza vaccines, the company announced in a statement Tuesday. Read the rest…

Vaccines 142

Vaccines Dosage 142